ScopusElsevier Scopus
Status
Active
Coverage
1981–present
Source type
Journal
Open access
No
CiteScore
7
SJR · SCImago
0.765
Q2 SJR quartile
H-index
76
Best quartile
Q2 · 72nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Drug Discovery | 45 / 161 | 72nd | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Development Research
Drug Development Research is Scopus-indexed (Q2, CiteScore 7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 0272-4391Verify ISSN ↗1098-2299Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Scopus · Q2WoS · SCIEONOS
7
CiteScore 2025
Q2
Best quartile
2
Indexed in
Cost to publish: About US$3,980 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Drug Development Research indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1981–present, best quartile Q2, CiteScore 7.
What quartile is Drug Development Research in Scopus?
Drug Development Research is Q2 in Drug Discovery (rank 45 of 161), by CiteScore 2025.
What is the impact factor of Drug Development Research?
Drug Development Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.765, quartile Q2, with an H-index of 76.
How much does it cost to publish in Drug Development Research?
The publisher lists an article processing charge of about US$3,980 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Drug Development Research and what is its ISSN?
Drug Development Research is published by John Wiley & Sons Inc. Its print ISSN is 0272-4391 and its online ISSN is 1098-2299.
Is Drug Development Research covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Drug Development Research in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Drug Development Research open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Drug Development Research? — open metrics via OpenAlex
Drug Development Research has an h-index of 97 and a 2-year mean of 3.66 citations per paper (OpenAlex). Its Scopus CiteScore is 7, quartile Q2. On 2-year citations it ranks #52 of 159 Scopus journals in Drug Discovery.
97
h-index
3.66
2-yr mean citations
1,944
i10-index
5,201
works indexed
74,682
total citations
Publication fee · open access list price, US$
US$3,980
2-yr mean citations, among Scopus journals in the same subject
#52 of 159 Top 33% Drug Discovery
Drug Development Research published 189 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Drug Development Research? — latest 99 articles, 2026
In its latest 99 research articles (2026), authors are most often from China (31.6%), India (14.6%) and Egypt (13.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Drug Development Research? — indicators, not proof of misconduct
Scopus status: Active. 9 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 9 · 1.7 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Earth's Future Scopus Q1 WoS SCIE DOAJ Electrical Engineering in Japan (English translation of Denki Gakkai Ronbunshi) Scopus Q4 WoS SCIE Electronics Letters Scopus Q3 WoS SCIE DOAJ Employment relations today Not in these indexes Energy and Environmental Materials Scopus Q1 WoS SCIE Environmental DNA Scopus Q1 WoS ESCI DOAJ Environmental Mutagenesis Not in these indexes Environmental Progress Not in these indexes
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.